A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two-year National Institutes of Health (NIH ) grant. They detail their work in a recent paper published in the Journal of Biochemistry (JBC): “Cell- Free Production of a Functional Oligomeric Form of a Chlamydia Major Outer Membrane Protein (MOMP) for Vaccine Development.” This work was performed in partnership with researchers at University of California, Davis and the vaccine group at Synthetic Genomics, Inc .